Overview
Saxenda is a branded liraglutide product — an earlier-generation GLP-1 receptor agonist. Whether it is appropriate for you is decided by your provider.
What Saxenda is
Saxenda is a branded liraglutide product, FDA-approved for specific conditions. It is an earlier-generation GLP-1 medication.
How it works
As a GLP-1 receptor agonist, Saxenda engages the same general pathway as semaglutide-class products, with a shorter duration of action.
When a clinician may consider it
Some clinicians and members prefer Saxenda's profile for specific scenarios. The decision is always individualized.
Side effects discussed during review
Side-effect profile is consistent with the GLP-1 class.
Cost & access
Coverage and pricing vary. The care team helps members understand options.


